WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

A Personal Farewell After 40 Years in the Pharma Industry After a 40-year career in the pharmaceutical industry, I officially retire today, June 1, 2026. With my retirement, WiCON International Group LLC, along with its last rem...
(6/1/2026)

A Personal Farewell After 40 Years in the Phar... (6/1/2026)

Pillars of Exclusivity: Regulatory Data Protec... (5/28/2026)

As Calls for COINS Act Expansion Grow, Will Ne... (5/27/2026)

China Biopharma Financing Rebounds Strongly in... (5/25/2026)

China Signals Continued Opening and Tougher Co... (5/25/2026)

Global Pharma and China Biotech Race Into a Ne... (5/20/2026)

The China question Is Tearing Biotech Apart (S... (5/19/2026)

China's RWE Evolution: From Pilot to Practice ... (5/18/2026)

Nature Analysis Highlights China's Rise as Glo... (5/18/2026)

Pharma CEOs Missing From Trump's China Delegat... (5/14/2026)

Life Sciences a "Sweet Spot" for U.S.-China Co... (5/14/2026)

China Emerges as Global Hub for siRNA Out-Lice... (5/11/2026)

A Personal Farewell After 40 Years in th... (6/1/2026) Recent Executive Moves (5/29/2026) CDE Launches Pilot Program to Accelerate... (5/29/2026) CDE Releases Draft Guideline on Clinical... (5/29/2026) CDE Seeks Comments on Draft Guideline fo... (5/29/2026) CDE Seeks Public Comments on Draft Bioeq... (5/29/2026) Hengrui Wins China Approval for SHR4640,... (5/29/2026) Helixmith-Linked Gene Therapy Engensis R... (5/29/2026) Ocumension Advances Presbyopia Pipeline ... (5/29/2026) InnoCare Announces the Acceptance of NDA... (5/29/2026) Cumberland Launches Vibativ® in China T... (5/29/2026) Pfizer and Innovent Forge $10.5B Global ... (5/29/2026) China Gene Editing Startup YolTech Raise... (5/29/2026) CR Thera Raises ~CNY 100M to Advance Nex... (5/28/2026) China Accelerates Approval of Home-Grown... (5/28/2026) Chinese Scientists Develop Broad-Spectru... (5/28/2026) Merck Wins China Approval for Poultry In... (5/28/2026) Dizal's ZEGFROVY Granted Priority Review... (5/28/2026)

China Innovative Drug Sales Climb as Commercial Insuran... China Pharma Market Set for Structural Shift as Innovat... China Pharmaceutical Market Projected to Reach US$573B ... China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T...

A Personal Farewell After 40 Years in the Pharma Indust... China Gene Editing Startup YolTech Raises $70M Ahead of... Pfizer and Innovent Forge $10.5B Global Oncology Allian... Cumberland Launches Vibativ® in China Thru SciClone Pa... CR Thera Raises ~CNY 100M to Advance Next-Gen Allogenei...

CDE Seeks Public Comments on Draft Bioequivalence Guide... CDE Seeks Comments on Draft Guideline for Use of Patien... CDE Releases Draft Guideline on Clinical Trial Design f... CDE Launches Pilot Program to Accelerate Development of... China Accelerates Approval of Home-Grown Innovative Dru...

China Expands Residency-Based Medical Insurance Access China Expands BMI Access Through Residency-Based Public... China to Establish "Whitelist" System to Curb Misuse of... China's 12th Centralized Drug Procurement Expands to Re... Major Study Warns Neurological Diseases Are Surging Acr...

Novartis Terminates Partnership with Chinese CDMO Porto... China Tightens Biopharma Supply Chain Controls, Raising... U.S. Lawmakers Push to Bar China Clinical Data From FDA... Bayer Secures Nearly Five-Year China Patent Extension f... U.S. ITC to Probe China's Trade Status and Biotech Prac...

FDA Warns Chinese API Manufacturer Over Relabeled GLP-1... Pakistan Emerges as New Target for Chinese Pharmaceutic... Chinese API Makers Raise Prices as Middle East Conflict... India Still Relies Heavily on China for Essential Pharm... Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See...

InnoCare Announces the Acceptance of NDA for Orelabruti... Ocumension Advances Presbyopia Pipeline as OT-802 Enter... Helixmith-Linked Gene Therapy Engensis Receives China A... Hengrui Wins China Approval for SHR4640, Expanding Meta... China Unveils AI Supercomputing Platform That Cuts Drug...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

A Personal Farewell After 40 Years ... 2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...